Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler

Share this content:
Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler
Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler

TUESDAY, Feb. 14, 2017 (HealthDay News) -- Delayed and recurrent orbital cellulitis following use of facial soft-tissue filler is described in a case report published online Feb. 10 in Clinical & Experimental Ophthalmology.

Paul Ikgan Sia, M.B.Ch.B., from the Royal Adelaide Hospital in Australia, and colleagues describe the case of a 49-year-old female who presented with 12 months of recurrent left cheek inflammation that did not resolve with six courses of antibiotics. She described a thickened, indurated, and erythematous area in her left cheek, which became worse after subcutaneous triamcinolone injection into the affected area. The extraocular movements on the left were significantly restricted on examination.

The researchers identified two orbital abscesses on magnetic resonance imaging, which were incised and drained, with subsequent recovery. Two months later the patient presented with a relapse of orbital cellulitis. On surgical exploration, a permanent left cheek cable suture was identified; gelatinous material was present at the inferior end of the suture. On further postoperative questioning, the patient confirmed having had nasojugal fold or lower cheek permanent soft-tissue filler injection and cheek-lifting cable sutures inserted six years earlier. The gelatinous material was confirmed as permanent silicone filler. The patient recovered and was free of recurrence at 12-months follow-up.

"Although orbital complications from soft-tissue fillers are very rare, they can be potentially sight-threatening," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »